SEC Form 4 · accession 0001055726-18-000047
INOVIO PHARMACEUTICALS, INC. · INO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Kies
Officer — CFO
Period of report
Nov 29, 2018
Accepted (ET)
Nov 30, 2018 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 29, 2018 | M | 10,001 | $2.00 | A | 72,089 | D | |
| Common StockF1 | Nov 29, 2018 | S | 10,001 | $5.28 | D | 62,088 | D | |
| Common Stock | holding | — | — | — | 4,500 | I | By Spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock OptionF2,F3 | $2.00 | Nov 29, 2018 | M | 10,001 | D | Dec 9, 2008 | Dec 9, 2018 | Common Stock | 10,001 | 0 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price.
- F2Gives effect to a 1-for-4 reverse stock split effected by the Issuer on June 5, 2014.
- F3The shares underlying this option vested and became exercisable on various dates between December 9, 2008 and December 9, 2011.